The impact of aspirin resistance on the long-term cardiovascular mortality in patients with non-ST segment elevation acute coronary syndromes.
Autor: | Foussas SG; Department of Cardiology, Tzanio Hospital, Piraeus, Greece., Zairis MN, Tsirimpis VG, Makrygiannis SS, Patsourakos NG, Adamopoulou EN, Mytas DZ, Prekates AA, Perdiou AJ, Tsoukanas VK, Argyrakis SK |
---|---|
Jazyk: | angličtina |
Zdroj: | Clinical cardiology [Clin Cardiol] 2009 Mar; Vol. 32 (3), pp. 142-7. |
DOI: | 10.1002/clc.20293 |
Abstrakt: | Background: Aspirin resistance has been associated with an adverse long-term outcome in patients with atherosclerotic coronary artery disease, but more studies are needed. Hypothesis: The aim of this study was to investigate the impact of aspirin resistance, assessed by the Platelet Function Analyzer-100 (PFA-100) (Dade Behring Inc., Deerfield, Ill., USA) on the long-term prognosis in patients with non-ST segment elevation acute coronary syndromes (NSTE-ACS). Methods: A total of 496 consecutive patients were studied. The 1-y incidence of cardiovascular death was the prespecified study endpoint. The patients were divided, according to the values of PFA-100 collagen epinephrine closure time (CEPI-CT) upon presentation, into aspirin sensitives (those with a PFA-100 CEPI-CT>193 sec) and aspirin resistants (those with a PFA-100 CEPI-CT (Copyright (c) 2009 Wiley Periodicals, Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |